join us
CN
Home page
About Us
Profile
Affiliates/Subsidiaries
Development History
Quality Management
Contact Us
Legal Statement
Adverse Reaction Report
Science and Technology
R&D platform
R&D pipeline
Therapeutic Field
International Business
APIs
Finished Products
Medical device
Download product list
Contact
News Center
News & Trends
Public information
News & Trends
07
2024-04
JK07 for the treatment of chronic heart failure in adults was approved for Phase II clinical trial in China Abstract: A Phase II clinical trial in adults with chronic heart failure (RENEU-HF) was initiated
14
2023-12
Salubris' innovative drugs Allisartan and Enarodustat® were enrolled into 2023 National Reimbursement Drug List(NRDL)
10
2023-10
New overseas clinical progress of JK07 for the treatment of chronic heart failure (HFrEF)
08
2023-10
SAL0120 tablets for treatment of IgA nephropathy approved for clinical trial
10
2023-08
Vena cava filter system (SaExten®) approved by NMPA
09
2023-06
ENARODUSTAT (ENONARRO®) aprovado pela NMPA para tratamento de anemia renal (Resumo) NMPA Aprovado por Enarodustat (EuNarro®)
Atualmente em primeiro lugar
1
Página,
Compartilhar
9
Página,
Compartilhar
51
Registros
Primeira página
Última página
1
2
3
4
5
Próxima página
a última página
redirecionar para
Página
map